Skip to content

Long COVID Diagnostic Reactivity Assesment Test

Development of a Personalized Alternative Non-invasive Rapid Diagnostic Test for SARS-CoV-2 in Patients With Long COVID

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07343856
Acronym
EAV-LONGCOVID
Enrollment
50
Registered
2026-01-15
Start date
2025-12-05
Completion date
2027-01-01
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long COVID, Post-Acute Sequelae of SARS-CoV-2 Infection

Keywords

Long COVID, Post-acute sequelae of SARS-CoV-2 infection, Bioelectrical assessment, Electroacupuncture diagnostics, Medicament testing, Autonomic dysregulation, Chronic viral persistence, Non-invasive diagnostics

Brief summary

This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing. The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances. The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.

Detailed description

This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing. The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances. The study involves a single-session, non-invasive diagnostic procedure without pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.

Interventions

DIAGNOSTIC_TESTElectrodiagnostic Bioelectrical Assessment

A non-invasive diagnostic procedure performed during a single session to assess bioelectrical response patterns associated with viral antigen persistence. Measurements are obtained using standardized bioelectrical assessment techniques without administration of any therapeutic agents or interventions.

Sponsors

Oncology Center,Ministry Of Heath,Uzbekistan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

All enrolled participants undergo a single-session diagnostic assessment using medicament testing to evaluate bioelectrical response patterns associated with viral persistence.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * History of confirmed SARS-CoV-2 infection * Persistent symptoms consistent with Long COVID lasting ≥12 weeks after acute infection * Ability to provide informed consent * Willingness to undergo non-invasive bioelectrical diagnostic assessment

Exclusion criteria

* Acute infectious disease at the time of enrollment * Severe uncontrolled medical or psychiatric conditions that may interfere with diagnostic assessment * Implanted electronic medical devices (e.g., pacemaker) * Pregnancy or breastfeeding * Inability to comply with study procedures

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Bioelectrical Response Patterns Consistent With Viral PersistenceAt enrollment (single diagnostic session)Non-invasive diagnostic assessment using electroacupuncture-based medicament testing to identify bioelectrical response patterns consistent with viral antigen persistence in participants with post-viral conditions.

Secondary

MeasureTime frame
Distribution of Bioelectrical Reactivity Patterns During Medicament TestingBaseline(Day 1)

Countries

Uzbekistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026